Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5K Sell
1,000
-1,000
-50% -$5.41K ﹤0.01% 9559
2014
Q2
$11K Buy
2,000
+1,000
+100% +$5.95K ﹤0.01% 8841
2014
Q1
$7K Sell
1,000
-21,400
-96% -$157K ﹤0.01% 9315
2013
Q4
$160K Buy
22,400
+15,400
+220% +$114K ﹤0.01% 5535
2013
Q3
$54K Buy
7,000
+1,100
+19% +$8.55K ﹤0.01% 6779
2013
Q2
$38K Buy
+5,900
New +$37.1K ﹤0.01% 7110

Other funds holding ELX

UBS's ELX Position: Q3 2014 in Review

UBS reduced its EMULEX CORP (ELX) stake by 3.3% in Q3 2014, selling an estimated $4.91K and leaving 26,786 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #5654.

UBS first reported a position in ELX in Q2 2013 and has held it in 6 quarters since. The position peaked at $183K in Q2 2013. 147 funds tracked by Wall St. Rank hold ELX as of Q3 2014.

  • UBS held 26,786 shares of EMULEX CORP worth $132K as of Q3 2014.
  • UBS sold 907 EMULEX CORP shares in Q3 2014, an estimated $4.91K.
  • EMULEX CORP made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5654 holding.
  • UBS first reported a position in EMULEX CORP in Q2 2013 and has held it in 6 quarters since.
  • UBS's EMULEX CORP position peaked at $183K in Q2 2013.
  • 147 funds tracked by Wall St. Rank held EMULEX CORP as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.